Cargando…
Strategies for Genetically Engineering Hypoimmunogenic Universal Pluripotent Stem Cells
Despite progress in developing cell therapies, such as T cell or stem cell therapies to treat diseases, immunoincompatibility remains a major barrier to clinical application. Given the fact that a host's immune system may reject allogeneic transplanted cells, methods have been developed to gene...
Autores principales: | Zhao, Wei, Lei, Anhua, Tian, Lin, Wang, Xudong, Correia, Cristina, Weiskittel, Taylor, Li, Hu, Trounson, Alan, Fu, Qiuli, Yao, Ke, Zhang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270609/ https://www.ncbi.nlm.nih.gov/pubmed/32502965 http://dx.doi.org/10.1016/j.isci.2020.101162 |
Ejemplares similares
-
Generation of universal and hypoimmunogenic human pluripotent stem cells
por: Ye, Qingsong, et al.
Publicado: (2020) -
Hypoimmunogenic Human Pluripotent Stem Cells as a Powerful Tool for Liver Regenerative Medicine
por: Trionfini, Piera, et al.
Publicado: (2023) -
Is hypoimmunogenic stem cell therapy safe in times of pandemics?
por: Matheus, Friederike, et al.
Publicado: (2022) -
Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application
por: Kitano, Yuko, et al.
Publicado: (2022) -
Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity
por: Chen, Yifan, et al.
Publicado: (2023)